Skip to main content

Find Clinical Trials

Home
Conditions
Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer

Clinical trial condition

Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer

Explore clinical trials studying Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer trial results

Recruiting

Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer

NCT06562920

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer, +8 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details